| Identification | Back Directory | [Name]
13,14-DIHYDRO-15(R)-PROSTAGLANDIN E1 | [CAS]
201848-10-4 | [Synonyms]
13,14-dihydro-15(R)-PGE1
13,14-DIHYDRO-15(R)-PROSTAGLANDIN E1
9-oxo-11α,15R-dihydroxy-prostan-1-oic acid
9-OXO-11ALPHA,15R-DIHYDROXY-PROSTAN-1-OIC ACID
Prostan-1-oic acid, 11,15-dihydroxy-9-oxo-, (11α,15R)- (9CI) | [Molecular Formula]
C20H36O5 | [MDL Number]
MFCD00135209 | [MOL File]
201848-10-4.mol | [Molecular Weight]
356.5 |
| Chemical Properties | Back Directory | [Boiling point ]
541.4±35.0 °C(Predicted) | [density ]
1.075±0.06 g/cm3(Predicted) | [solubility ]
DMF: >100 mg/ml (from PGE1); DMSO: >50 mg/ml (from PGE1); Ethanol: >50 mg/ml (from PGE1); PBS pH 7.2: >1.6 mg/ml (from PGE1) | [pka]
4.77±0.10(Predicted) |
| Hazard Information | Back Directory | [Uses]
13,14-dihydro-15(R)-Prostaglandin E1 (13,14-dihydro-15(R)- PGE1) is an analog of 13,14-dihydro- PGE1 which has the hydroxyl group at C-15 in the unnatural R configuration[1]. | [Definition]
ChEBI: 13,14-dihydro-15(R)-Prostaglandin E1 is a prostanoid. | [References]
[1] Sinzinger H, et al. PGE1 and 13, 14-dihydro-PGE1 Increase Low-Density Lipoprotein Receptors and Improve Arterial Wall Lipid Metabolism//Prostaglandin E1: New Aspects on Pharmacology, Metabolism and Clinical Efficacy. Berlin, Heidelberg: Springer Berlin Heidelberg, 1991: 39-48. |
|
| Company Name: |
AXXORA, LLC
|
| Tel: |
+41 (0) 61 926 8989 |
| Website: |
www.axxora.com |
|